Spineway Nine — Month Revenue Falls 7% to EUR 8.03 Million

Spineway’s revenue for the first nine months of 2026 fell 7% to €8.03 million. Third-quarter revenue declined 25% to €2.29 million as supply constraints affected certain product ranges. Latin American nine-month sales dropped 33% to €1.9 million amid supply constraints and election-related slowdowns. Asian sales rose 27% to €1.9 million, driven by new accounts and demand for disc prostheses. Erwan Martin became deputy chief executive officer on October 1, 2026, having previously served as chief financial officer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spineway SA published the original content used to generate this news brief via (Ref. ID: 202610151205OMX_____CNEWS_EN_GNW1001278165_en) on October 15, 2026, and is solely responsible for the information contained therein. (C)